Message from CEO: April 2025
Today marks a defining moment in the history of Ocumetics—and in the future of vision restoration worldwide.It is with great pride and anticipation that I share we are now entering the final stages before our First-In-Human (FIH) clinical study for the Ocumetics Lens. This is more than a corporate milestone; it is the beginning of



